Cytarabine and daunorubicin liposomal and Xpovio (60 MG Once Weekly)
Determining the interaction of Cytarabine and daunorubicin liposomal and Xpovio (60 MG Once Weekly) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: cytarabine liposomal / daunorubicin liposomal
Brand name: Vyxeos
Synonyms: Cytarabine and daunorubicin (liposomal), Daunorubicin and Cytarabine (Liposomal)
Generic Name: selinexor
Brand name: Xpovio
Synonyms: Xpovio
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Cytarabine and daunorubicin liposomal-Xpovio (80 MG Once Weekly)
- Cytarabine and daunorubicin liposomal-Xpovio (80 MG Twice Weekly)
- Cytarabine and daunorubicin liposomal-Xryliderm
- Cytarabine and daunorubicin liposomal-Xrylix
- Cytarabine and daunorubicin liposomal-Xtampza ER
- Cytarabine and daunorubicin liposomal-Xtandi
- Xpovio (60 MG Once Weekly)-Cytarabine liposome Intrathecal
- Xpovio (60 MG Once Weekly)-CytoGam
- Xpovio (60 MG Once Weekly)-Cytogam injection
- Xpovio (60 MG Once Weekly)-Cytomegalovirus immune globulin (CMV IG) injection
- Xpovio (60 MG Once Weekly)-Cytomegalovirus Immune Globulin (Intravenous-Human)
- Xpovio (60 MG Once Weekly)-Cytomegalovirus Immune Globulin IV